← All organizations

Advenchen Laboratories, LLC

For profitWebsite ↗

Also known as: Advenchen Laboratories, LLC | Advenchen Laboratories Nanjing Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 21, 2025

Timeline

2000s

Jun 1, 2003
Advenchen Laboratories, LLC— Founded

Drugs by trial phase (7 distinct, 12 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

al58805

Indications

Studied for

Recent trials (14)

NCT05612191Lead sponsorN/A—
NCT07132957Lead sponsorPhase 1Feb 21, 2025
NCT06247605Lead sponsorPhase 3Oct 26, 2023
NCT05486598Lead sponsorPhase 1Jun 21, 2022
NCT06794957Lead sponsorPhase 1May 19, 2022
NCT07179081Lead sponsorPhase 1Dec 20, 2020
NCT04890795Lead sponsorPhase 1/Phase 2Oct 19, 2020
NCT04165330CollaboratorPhase 1/Phase 2Oct 17, 2019
NCT04890587Lead sponsorPhase 1Aug 17, 2017
NCT03016819Lead sponsorPhase 3Apr 1, 2017
NCT02584478Lead sponsorPhase 1/Phase 2Dec 1, 2015
NCT02584478Study directorPhase 1/Phase 2Dec 1, 2015
NCT02558348Lead sponsorPhase 1/Phase 2Nov 1, 2015
NCT02558348Study directorPhase 1/Phase 2Nov 1, 2015

Details

Founded: Moorpark, CA, US Jun 1, 2003
Last known activity: Feb 21, 2025